| Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19 Y Zaid, F Puhm, I Allaeys, A Naya, M Oudghiri, L Khalki, Y Limami, N Zaid, ... Circulation research 127 (11), 1404-1418, 2020 | 474 | 2020 |
| Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence PM D'Aoust, E Mercier, D Montpetit, JJ Jia, I Alexandrov, N Neault, ... Water research 188, 116560, 2021 | 332 | 2021 |
| Humoral responses and serological assays in SARS-CoV-2 infections Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois Frontiers in immunology 11, 610688, 2020 | 244 | 2020 |
| Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities MA Langlois, RCL Beale, SG Conticello, MS Neuberger Nucleic acids research 33 (6), 1913-1923, 2005 | 222 | 2005 |
| DNA deamination in immunity: AID in the context of its APOBEC relatives SG Conticello, MA Langlois, Z Yang, MS Neuberger Advances in immunology 94, 37-73, 2007 | 203 | 2007 |
| Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells MA Langlois, C Boniface, G Wang, J Alluin, PM Salvaterra, J Puymirat, ... Journal of Biological Chemistry 280 (17), 16949-16954, 2005 | 151 | 2005 |
| Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo E Takeda, S Tsuji-Kawahara, M Sakamoto, MA Langlois, MS Neuberger, ... Journal of virology 82 (22), 10998-11008, 2008 | 135 | 2008 |
| Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts MA Langlois, NS Lee, JJ Rossi, J Puymirat Molecular Therapy 7 (5), 670-680, 2003 | 131 | 2003 |
| Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions D Furling, G Doucet, MA Langlois, L Timchenko, E Belanger, L Cossette, ... Gene therapy 10 (9), 795-802, 2003 | 115 | 2003 |
| HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence DH Kim, MA Langlois, KB Lee, AD Riggs, J Puymirat, JJ Rossi Nucleic acids research 33 (12), 3866-3874, 2005 | 107 | 2005 |
| Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses K Belanger, M Savoie, MC Rosales Gerpe, JF Couture, MA Langlois Nucleic acids research 41 (15), 7438-7452, 2013 | 99 | 2013 |
| Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration JA Welsh, E van der Pol, BA Bettin, DRF Carter, A Hendrix, M Lenassi, ... Journal of Extracellular Vesicles 9 (1), 1816641, 2020 | 94 | 2020 |
| A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, KT Abe, ... Clinical & translational immunology 11 (3), e1380, 2022 | 80 | 2022 |
| The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3 MA Langlois, K Kemmerich, C Rada, MS Neuberger Journal of virology 83 (22), 11550-11559, 2009 | 71 | 2009 |
| A novel semiconductor-based flow cytometer with enhanced light-scatter sensitivity for the analysis of biological nanoparticles GC Brittain IV, YQ Chen, E Martinez, VA Tang, TM Renner, MA Langlois, ... Scientific reports 9 (1), 16039, 2019 | 68 | 2019 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of Extracellular Vesicles 13 (2), e12404, 2024 | 66 | 2024 |
| Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1 MA Langlois, MS Neuberger Journal of Virology 82 (9), 4660-4664, 2008 | 58 | 2008 |
| Insights into DNA deaminases SG Conticello, MA Langlois, MS Neuberger Nature structural & molecular biology 14 (1), 7-9, 2007 | 50 | 2007 |
| Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2 Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, ... EBioMedicine 74, 2021 | 48 | 2021 |
| Adapting serosurveys for the SARS-CoV-2 vaccine era N Duarte, M Yanes-Lane, RK Arora, N Bobrovitz, M Liu, MG Bego, T Yan, ... Open forum infectious diseases 9 (2), ofab632, 2022 | 40 | 2022 |
